Our study provides the first proof‐of‐concept for the delivery of DNase I using biomimetic cellular nanovesicles, which presents a promising therapeutic intervention strategy for ALI/ARDS. The gene discussed is DNASE1; the disease is acute respiratory distress syndrome.